HLN
Haleon Plc
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · GB
$9.28
−0.85%Next report
Analyst consensus
- Next report date
- Mar 4, 2027
- EPS estimate
- $0.29
- Revenue estimate
- $7.8B
Latest reported
- Last report date
- Jul 30, 2026
- EPS actual
- $0.28
- EPS estimate
- $0.27
- Revenue actual
- $7.5B
- Revenue estimate
- $7.4B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -25.8%
- Revenue beats (12Q)
- 6
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 30, 2026 | $0.27 | $0.28 | Beat 3.63% | $7.5B |
| Feb 25, 2026 | $0.25 | $0.26 | Beat 3.38% | $7.5B |
| Oct 30, 2025 | $0.24 | $0.14 | Miss -42.83% | $7.5B |
| Aug 7, 2025 | $0.24 | $0.08 | Miss -67.33% | $7.3B |
| Feb 27, 2025 | $25 | $0.05 | Miss -99.80% | $7.1B |
| Oct 31, 2024 | $0.11 | $0.14 | Beat 27.27% | $6.9B |
| May 1, 2024 | $0.11 | $0.12 | Beat 9.09% | $7.2B |
| Feb 29, 2024 | $10 | $6.54 | Miss -36.32% | $7.0B |
| Aug 2, 2023 | $0.22 | $0.08 | Miss -63.50% | $7.3B |
| Mar 2, 2023 | $0.23 | $0.21 | Miss -9.70% | $6.8B |
| Sep 20, 2022 | $0.22 | $0.22 | Miss -1.57% | $5.9B |
| Dec 31, 2021 | — | $0.11 | — | $3.4B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 4, 2027